SOURCE: G2 Intelligence

G2 Intelligence

September 30, 2011 11:54 ET

Lab Industry Visionary Dr. Tom Tiffany to Be Honored at 29th Annual Lab Institute

G2 Intelligence and Sponsor Kellison & Company Will Present Dr. Tiffany With the 2011 Laboratory Public Service National Leadership Award

PETERBOROUGH, NH--(Marketwire - Sep 30, 2011) - G2 Intelligence announces an important event to take place during Lab Institute 2011, October 19-21, 2011, at the Crystal Gateway Marriott in Arlington, Virginia. Dr. Thomas Tiffany, a distinguished 40-year veteran of the biomedical field, will receive the 2011 Laboratory Public Service National Leadership Award from G2 Intelligence.

Dr. Tiffany, who has announced his retirement from PAML (Pathology Associates Medical Laboratories) after serving as their chief executive officer for 23 years, is a well-known, highly-regarded business leader who recently led PAML to form an important new partnership with Catholic Health Initiatives (CHI), and landed his company on both the Seattle Business Journal and Modern Healthcare magazine's best places to work in Washington lists.

"We're truly thrilled to be honoring Dr. Tiffany at this year's Lab Institute," according to Dennis Weissman, Executive Editor and program chair for G2 Intelligence. "He's a real industry visionary who developed and successfully implemented an innovative joint venture partnership model with local health systems in more than a half dozen states. Tom's legacy will live on following his retirement within the organizations he has grown as well as inside the wider lab sector due to his groundbreaking work in convincing hospital executives to leverage their outreach lab testing to a wider strategic purpose."

As the premier learning and networking event for the lab industry, Lab Institute 2011 promises its most comprehensive agenda yet, with an impressive roster of industry-leading speakers, and insightful sessions, workshops and targeted breakout sessions.

Attendees will explore critical developments with this year's keynote speakers:

  • David King, Chairman and CEO, Laboratory Corporation of America and Chairman, American Clinical Laboratory Association
  • Susan Dentzer, Editor-in-Chief of Health Affairs and Policy Analyst for PBS
  • Misha Angrist, Ph.D., Assistant Professor of the Practice, Duke Institute for Genome Sciences and Policy, Visiting Lecturer, Sanford School of Public Policy, and author of Here Is a Human Being: At the Dawn of Personal Genomics

Distinguished faculty in attendance to include:

  • Gary S. Assarian, DO, FCAP
  • James Crawford, M.D., Ph.D. Senior Vice President, Laboratory Services, North Shore-LIJ Health System; Chair, Department of Pathology, Hofstra North Shore-LIJ School of Medicine
  • Carla Dewberry, Garvey Schubert Barer
  • Paul W. Edgett, III Senior Vice President, National Business Lines, Catholic Health Initiatives
  • Robin A. Felder, Ph.D., Professor and Associate Director of, Clinical Chemistry and Toxicology, University of Virginia School of Medicine
  • David Gee, Partner, Garvey Schubert Barer
  • James Giszczak, Member, McDonald Hopkins, LLC
  • Alberto Gutierrez, Ph.D., Director, Office of In Vitro Diagnostic Device Evaluation and Safety, U.S. Food and Drug Administration
  • N.Todd Hancock, Vice President of Operations, Trinity Mother Frances Hospitals and Clinics
  • Craig Holden, President and Chief Operating Officer, Ober|Kaler
  • Patric Hooper Esq., Founding Partner, Hooper Lundy Bookman
  • Paul Keoppel, MBA, MT(ASCP) Laboratory Compliance Officer, Intermountain Healthcare
  • Jondavid Klipp, President and Publisher, Laboratory Economics, LLC
  • Tara Kochis, President, Slone Partners
  • Jorge Leon, Ph.D., President, Leomics
  • Kandice Kottke-Marchant, M.D., Ph.D., Chair, Pathology and Laboratory Medicine Institute, Cleveland Clinic
  • Alan Mertz, President, American Clinical Laboratory Association
  • Joe Miles, MT(ASCP), MHS, Senior Consultant, Outreach Development, ARUP Laboratories
  • David Nichols, MBA, President & Founder, Nichols Management Group
  • Barry Portugal, President, Health Care Development Services, Inc.
  • Chris Riedel, CEO, Hunter Laboratories
  • Joe Seestadt, Director of Continuous Improvement, Cleveland Clinic
  • Karim E. Sirgi, M.D., Partner & President, UniPath, PC
  • Melinda Thiel, Vice President, DNA Direct by Medco Medco Health Solutions, Inc.
  • Marshal A. Thompson, Manager, Cleveland IT Operations, Predictive Biosciences
  • Louie Tzoumbas, Founder/Managing Principal, Omega Outreach Solutions
  • Diana Voorhees, Principal/CEO, DV & Associates, Inc.
  • Rina Wolf, Vice President of Commercialization Strategies, Consulting, and Industry Affairs, Xifin
  • Judy Yost, Director, Division of Laboratory Services, Centers for Medicare and Medicaid Services
  • Mary M. Zutter, M.D. Assistant Vice Chancellor for Integrative Diagnostics, Louise B. McGavock Chair, Professor of Pathology, Microbiology & Immunology and Cancer Biology, Director of Hematopathology, Director, Tumor-Host Interaction Program, Vanderbilt Ingram Cancer Center, Scientific Director, Human Tissue Acquisition & Pathology Core

To find out more, or to register for the 2011 Lab Institute event, go to or call 1.800.401.5937.

Group discounts are available for three or more people from the same organization. For group registrations, please call Jeff Watkins at 973.718.4709 to facilitate your registration, or email

About Lab Institute 2011

With over 500 thought leaders and hundreds of critical topics dissected over the past 28 years, Lab Institute remains one of the longest-running health care forums in the nation's capital. Since 1983, thousands of professionals in the laboratory and broader diagnostic industries have attended this premier learning and networking event.

From effectively navigating legislative changes and planning for the months ahead to growing profitability to leveraging emerging technologies -- Lab Institute promises balanced intelligence and insights on major policy and business issues affecting the lab and pathology sectors. In addition, Lab Institute serves as a unique platform for networking among laboratory, pathology/health system constituencies nationwide.

About G2 Intelligence

Advancing the Business of Diagnostic Medicine

G2 Intelligence provides timely, accurate and trusted analysis of industry and market trends, legal and regulatory developments, and technology and innovation that directly affect the operations, financial performance and competitive position of diagnostic testing laboratories and related medical services providers.

Formerly known as "Washington G-2 Reports", the company has covered and reported on the diagnostic industry for over 30 years. G2 Intelligence delivers topical and analytical periodicals, proprietary research studies, and custom advisory services, and through live and virtual events, facilitates industry meetings and information exchanges.

Our mission is to deliver relevant, meaningful and actionable findings on diagnostic industry markets, related regulatory changes, and lab operations. The organization strives to exceed client expectations and develop mutually beneficial relationships with industry leaders and influencers.

G2 Intelligence is a division of Kennedy Information, LLC a leading provider of professional markets analysis.

More information is available for you at

Contact Information

  • Contact:
    Dan Houder
    COO and Publisher, G2 Intelligence
    Email Contact